Edinburgh, Scotland, 23-1-2015 — /EuropaWire/ — Cairn is pleased to announce the completion of the farm out agreement to Dyas UK Limited for the sale of a 10% interest in the Catcher development and adjacent acreage in the UK North Sea for a carry of Cairn’s exploration and development costs up to a cap of US$182 million (m) effective 1 January 2014. The Catcher development is on track for first oil from 2017.
As a result of the transaction, Cairn has reduced its forward capital expenditure to the end of 2017 by ~US$380m. Cairn retains a 20% working interest in the Catcher licence.
Cairn, through its wholly owned subsidiary Capricorn Norge AS, has also been awarded the following non-operated interests in five licences in the Norwegian 2014 APA Licensing Round. These licences do not carry firm well commitments and are in locations adjacent to current areas of interest in Norway.
PL 788: 34/9 and 35/4, 5, 7, 8, 10
Wintershall 50%
Cairn 50%
PL787: 35/9
Bayerngas 40%
Wintershall 30%
Cairn 30%
PL 790: 34/2, 5
Det norske 50%
Spike 25%
Cairn 25%
PL 159 E: 6507/3
Statoil 42%
E.ON 40%
Cairn 18%
PL 800: 6508/1, 2
EnQuest 35%
Cairn 35%
Skagen44 30%
Enquiries:
Analysts/Investors | ||
---|---|---|
David Nisbet | Corporate Affairs | 0131 475 3000 |
Media | ||
---|---|---|
Patrick Handley | Brunswick Group LLP | 0207 404 5959 |
David Litterick | Brunswick Group LLP | 0207 404 5959 |
(IN BRIEF) Eurex, on April 29, 2024, introduced a new Green Bond Basket within its…
(IN BRIEF) Last Friday, NMB Bank Plc celebrated the listing of its dual-currency sustainability bond,…
(IN BRIEF) CapMan Nordic Infrastructure II fund has reached its final closing at over €375…
(IN BRIEF) AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated…
(IN BRIEF) AstraZeneca's Truqap, in combination with Faslodex, has received a positive recommendation from the…
(IN BRIEF) Ørsted, a global leader in renewable energy, is divesting its French onshore operations…